Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chikungunya
Pharma
Valneva rallies behind launch of its new chikungunya vaccine
After coming up short in an attempt to find a niche for its COVID vaccine, Valneva is focused on launching its new chikungunya virus vaccine Ixchiq.
Kevin Dunleavy
Apr 18, 2024 12:02pm
FDA signs off on Valneva's chikungunya vaccine Ixchiq
Nov 10, 2023 9:55am
Emergent sells 3 vaccines to Bavarian Nordic for $270M-plus
Feb 15, 2023 8:56am
Valneva has poached a vaccine marketing exec from GSK
Nov 17, 2022 10:15am
Themis’ chikungunya vaccine nabs fast FDA review
Feb 26, 2019 11:57am
Valneva looking to buy overlooked vaccines from Big Pharma: CEO
Jan 16, 2019 9:36am
